Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group

Transplant Proc. 1993 Feb;25(1 Pt 1):641-3.
No abstract available

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Age Factors
  • Analysis of Variance
  • Chronic Disease
  • Cyclosporine / therapeutic use*
  • Drug Resistance
  • Female
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Function Tests
  • Liver Transplantation / immunology*
  • Liver Transplantation / physiology
  • Male
  • Multivariate Analysis
  • Prognosis
  • Sex Characteristics
  • Survival Analysis
  • Tacrolimus / adverse effects
  • Tacrolimus / blood
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus